Why Is No One Talking About Viatris Stock?
A lot of people who own Viatris (NASDAQ: VTRS) stock didn't even buy it. That's because Viatris was formed through the merger of Mylan and Upjohn, the generics unit of Pfizer (NYSE: PFE). Pfizer shareholders were given a little more than 12 shares in Viatris for every 100 they held in Pfizer. Mylan shareholders got a Viatris share for every previous Mylan share they held.
Viatris stock is down more than 19% this year, but this provides a good buying opportunity.
Image source: Getty Images.
Source Fool.com
